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This report highlights the difﬁculty for both
patient and physician of the diagnosis and man-
agement of this rare disease.
Case report
A 48-year-old woman presented to the Accident
and Emergency department (A&E) with a
two-day history of swelling and pain in the left
buttock. She had a past historyof hypothyroidism,
depression and a hysterectomy for menorrhagia.
Clinically there was a soft, diffuse, tender mass
in the left buttock, with no evidence of abscess
or cellulitis. Blood tests including inﬂammatory
markers were normal. The surgical team sus-
pected a diagnosis of a lipoma and discharged
the patient with an outpatient ultrasound scan
(USS).
The patient re-attended A&E three weeks later
with increased buttock swelling and discomfort.
The USS reported an irregular hypoechoic mass
6.9 × 4.5 × 3.2 cm in size situated 2 cm deep to the
skin and extending towards the medial aspect of
the left buttock, suggestive of an abscess.
However, the clinical examination did not corre-
late with the radiological diagnosis and the
patient was discharged following a brief admis-
sion for analgesia. An outpatient magnetic reson-
ance imaging (MRI) scan was arranged.
The MRI suggested a large pelvic liposarcoma
and hence a staging CT scan was done (Figures
1, 2 and 3). This reported the soft tissue mass dis-
placing the bladder and rectum as it extends from
the level of sacroiliac joints and through the
greater sciatic notch into the buttock. The CTcon-
cludesthat a sarcoma is less likelya diagnosisthan
a cystic neoplasm. The patient was referred to a
consultant surgeon at a regional Sarcoma Unit
for treatment.
An elective admission was arranged for full
excision of the tumour via an incision into the
buttock, and the patient was discharged at day
10. The main complications postoperatively were
pain and a haematoma which discharged spon-
taneously. Histology conﬁrmed an aggressive
pelvic angiomyxoma. The patient is currently
under follow-up with repeat MRI scans to assess
for local recurrence and is awaiting further investi-
gationofasuspiciouslesionseenathermostrecent
scan, only 12 months post-primary resection.
Discussion
Buttock and perineal swellings are common pre-
sentations to both the general surgeon and gynae-
cologist, either on call or in clinic. Aggressive
angiomyxoma is a very rare differential diagnosis
for such cases.
Aggressive angiomyxoma was ﬁrst described
in 1983 by Steeper and Rosai
1 and, according to
literature, there have been fewer than 250 reported
cases worldwide.
2 It is a slow-growing benign
mesenchymal neoplasm which is characterized
by its tendency for local tissue inﬁltration and
recurrence, even many years after resection.
Metastases are very rare with only two reported
cases in world literature where multiple meta-
stases led to the death of both patients.
3
It more commonly presents as a vulval or peri-
neal tumour, although there are reports of its
manifestation at other sites outside the pelvis.
4
These tumours are almost always seen in women
in their third and fourth decades of life but cases
in men have also been reported, having presented
as scrotal swellings and been mistaken for hernias
or hydroceles.
5 Presentation is generally as an
asymptomatic soft tissue tumour often slow-
growing over many years, making our case
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1unusual in that the patient complained of a short
history of a painful buttock lump.
Given the rarity of the condition and its rela-
tively non-descript clinical presentation, it is
almost impossible to suspect the diagnosis at
ﬁrst encounter.
6 This explains the high rate of
initial mis-diagnosis, and hence delayed treat-
ment, of such tumours.
Surgery is the mainstay of treatment for aggres-
sive angiomyxoma. Adequate surgical clearance is
important in reducing recurrence rates but such
wide excision of these usually large tumours
carries a high morbidity. More recently, authors
are describing a less radical approach to surgical
excision with the aid of adjuvant therapy. Other
treatment modalities have been used to treat
both the primary and recurrent disease and these
include chemotherapy, radiotherapy, vessel embo-
lization and hormone suppression. Chemotherapy
and radiotherapy are unlikely to be of certain
beneﬁt due to the low mitotic activity of the
tumour cells. Preoperative vessel embolization is
generally used to aid identifying the abnormal
tissue at the time of resection and is also reported
to shrink the tumour in some cases.
7 The majority,
but not all, of aggressive angiomyxomas are oes-
trogen and progesterone receptor positive which
has lead to the use of gonadotropin-releasing
hormone (GnRH) agonists in their treatment.
8,9
GnRH agonists bind to receptors and initially
increase the release of FSH and LH, and hence oes-
trogen and progesterone. However, after approxi-
mately 10 days of treatment, down-regulation of
receptors is achieved by their internalization and
a decrease in hormone levels results. Indeed,
some reports have shown full radiological resolu-
tion of tumour with the use of GnRH agonists in
cases of both primary and recurrent tumours.
For this reason, it is suggested by some authors
that GnRH agonists should form part of the treat-
ment protocol in order to obviate the need for
radical pelvic surgery in hormone receptor posi-
tive patients. More recently, one report of the suc-
cessful use of an aromatase inhibitor in the
treatment of angiomyxoma has been published,
describing its use to shrink the tumour prior to
resection.
10 This treatment modality works by
blocking the enzyme aromatase from synthesizing
oestrogen.
Recurrence rates ranging between 9–72% have
been reported from various case series, the
Figure 1
Coronal section MRI scan showing tumour
extending from pelvis into left buttock
Figure 2
Sagittal section MRI scan of pelvis and perineum
showing mass extending into buttock
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2spectrum being wide due to the low incidence of
the disease and the variations in length of
follow-up as well asthe fact that many recurrences
develop several years following the primary
tumour. This emphasizes the need for long-term
surveillance and follow-up of these patients.
Insummary,althougharareandbenigntumour,
aggressive angiomyxoma may cause signiﬁcant
symptoms if large and surgical resection carries a
high morbidity. Adjuvant medical therapies
should be discussed and follow-up must be long-
term with repeat MRI or CTscanning.
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Figure 3
CT scan of pelvis showing tumour mass displacing bladder and
rectum
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